Pró Genéricos When we last interviewed you in 2007, you said, “The generics business is a very exciting one,” but you “regret[ted] that the Government is not doing enough work to promote it.” At that time, generics penetration was around 10.5% – now it’s around 20%. Does this reflect some fundamental change…
Productos Roche S.A. What has been the evolution of Roche’s operations in Colombia’s over the course of its proud 52-year history here? As with almost all pharmaceutical companies with commercial operations in Latin America, we began our business here in Colombia with a production plant. The plant has closed since 1997 as our…
NEPROFARM In order to understand the culture behind the business that this association represents, what would you say is the perception of OTC and non-prescriptive drugs in the Netherlands? OTC medicines are the medication of choice in the Netherlands. Most people will have some OTC medicines in his cabinet and indeed,…
Cockram Projects India is clearly a new location for Cockram, and what brought you here was your loyal customer Pfizer. After 3 years of project work, a permanent business has now also been established in India since 2010. Can you tell us how this first project worked out for you here? In…
Sdružení výrobců volně prodejných léčivých přípravků (SVOPL-OTC) Mr. Kotek, can you please begin by introducing us to the SVOPL and telling us what the mission is here in the Czech Republic? We are a relatively new Association that was founded only back in 2000. Before, we were a branch of a larger Association of international drug producers…
Qatar Investment Promotion Department (IPD) Mr. Alderbesti, can you please begin by giving our readers an overview of the core agenda of the Investment Promotion Department of the Qatari Ministry of Trade and Industry since you took the reins of the organization, and the role of healthcare and life sciences in your activities? I will…
Productos Medix S.A. de C.V. Can you tell us a little about the history of Medix and about the company itself? Medix is a 100% Mexican company created in 1956, and our major strength is that we produce products and services that are differentiated from the rest of the market, and have added-value. When Medix…
Protek In spring of 2010, Protek became the first Russian wholesaler to enter the public stock market, raising $400Mn in the biggest Russian IPO since 2007. You offered the IPO directly after the world financial crisis, which hit Russia particularly hard. Why did you choose this very risky period for the…
Roche Products (India) Pvt. Ltd. There is no doubt that India has become a country of rising opportunities. Can you first elaborate how important India has become for the Group worldwide? India has become very important, mainly because of the rising middle class population in the country. One of the problems with India however, is…
Union of Professional Pharmaceutical Organizations (SPFO) Last time Focus Reports met with you in 2006, the Russian pharmaceutical industry had enjoyed five straight years of growth. This growth has since continued through 2011. Can you provide some insight on what has happened in the industry since 2006, and how the market has been able to maintain…
Organisation of Pharmaceutical Producers of India (OPPI) Our last report on India dates back to 2006, right after the Patent Law was passed. What developments have you seen happening in the industry since then? There has been a paradigm shift with the Product Patent Regime coming in place in 2005. The era from 1970 to 2005 has…
Promega Netherlands Promega is a truly global company with a vast international presence. What would you say is the strategic importance that the Benelux affiliate has assumed within Promega’s global network? Promega Benelux is actually the first branch office that was established outside of the US, so the company’s experience in bringing…
See our Cookie Privacy Policy Here
